Pfizer Sues To Invalidate Amgen Plasma Cell Drug Patent
Pharmaceutical giant Pfizer has hit a rival, Amgen, with a lawsuit seeking to invalidate a patent, saying it lacks invention for components for drugs used to prevent and treat plasma cell...To view the full article, register now.
Already a subscriber? Click here to view full article